在阿诺基斯抗性中代谢重编程和信号适应:机制和治疗点
1Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
癌细胞避开细胞死亡过程的阿诺基斯,使得转移成为可能. 本综述详细介绍了诸如上皮层-介质细胞过渡和代谢变化等机制,强调了抑制癌症扩散的治疗标.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 阿诺基斯,在细胞外基质脱离时被编程的细胞死亡,维持组织平衡.
- 癌细胞获得耐药性,以幸存脱离并促进远程转移.
- 悬浮癌细胞中蛋白质表达的改变表明了显著的代谢和信号通路变化.
研究的目的:
- 审查驱动癌细胞耐药性的调节机制.
- 探索表皮层-介质细胞过渡,癌症干细胞,代谢重编程和信号通路的作用.
- 确定潜在的治疗点,包括试剂和非编码RNA,以抑制癌症的进展和转移.
主要方法:
- 关于阿诺基斯在癌症中的耐药性现有文献的综述.
- 对悬浮与附着癌细胞中差异表达蛋白质的分析.
- 确定关键的监管途径和潜在的治疗干预措施.
主要成果:
- 表皮-介质细胞过渡,癌症干细胞特征,代谢重编程和信号通路变化是阿诺基斯耐药性的关键.
- 针对这些途径的特定试剂和非编码RNA显示了治疗应用的潜力.
- 了解这些机制对于制定针对瘤进展和转移的策略至关重要.
结论:
- 阿诺基斯的逃避是癌症转移的一个关键步骤.
- 针对参与阿诺基斯耐药性的途径提供了有希望的治疗策略.
- 对这些机制的进一步研究可能会导致抑制癌症传播的新型治疗方法.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of the Unfolded Protein Response
